ACE and cervical cancer: The primary aim of this clinical study is to determine the impact of ACE inhibitors, β-blockers and other potential risk factors such as the patient’s pelvic and anatomical characteristics on ART emergence in patients with locally advanced cervical cancer treated by chemoradiotherapy.